TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 18 filers reported holding TRANSCODE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,098 | -49.7% | 15,060 | 0.0% | 0.00% | -66.7% |
| Q4 2022 | $10,135 | -40.4% | 15,060 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $17,000 | -10.5% | 15,060 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $19,000 | -55.8% | 15,060 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $43,000 | +13.2% | 15,060 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $38,000 | -15.6% | 15,060 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $45,000 | – | 15,060 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|